132 related articles for article (PubMed ID: 8306496)
61. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
62. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
[TBL] [Abstract][Full Text] [Related]
63. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
64. Idiotypic determinants on human T cells and modulation of human T cell responses by anti-idiotypic antibodies.
Geha RS
J Immunol; 1984 Oct; 133(4):1846-51. PubMed ID: 6206140
[TBL] [Abstract][Full Text] [Related]
65. Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells.
Chirmule N; Kalyanaraman VS; Slade H; Oyaizu N; Pahwa S
Clin Exp Immunol; 1990 May; 80(2):161-6. PubMed ID: 1972670
[TBL] [Abstract][Full Text] [Related]
66. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
Tanaka Y; Sugamura K; Hinuma Y
J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
[TBL] [Abstract][Full Text] [Related]
67. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA.
Molinari M; Salio M; Galli C; Norais N; Rappuoli R; Lanzavecchia A; Montecucco C
J Exp Med; 1998 Jan; 187(1):135-40. PubMed ID: 9419220
[TBL] [Abstract][Full Text] [Related]
68. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
69. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
70. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
71. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
Chu E; Umetsu D; Rosen F; Geha RS
J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
[TBL] [Abstract][Full Text] [Related]
72. Fc gamma RII on human B cells can mediate enhanced antigen presentation.
Liu C; Gosselin EJ; Guyre PM
Cell Immunol; 1996 Feb; 167(2):188-94. PubMed ID: 8603427
[TBL] [Abstract][Full Text] [Related]
73. One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation.
Nisini R; Fattorossi A; Ferlini C; D'Amelio R
Eur J Immunol; 1996 Apr; 26(4):797-803. PubMed ID: 8625970
[TBL] [Abstract][Full Text] [Related]
74. Human T cell clones specific for tetanus toxoid: characterization of antigen specificity and HLA restriction.
Schmitt C; Ballet JJ; Agrapart M; Bizzini B
Eur J Immunol; 1982 Oct; 12(10):849-54. PubMed ID: 6184238
[TBL] [Abstract][Full Text] [Related]
75. Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cells.
Villiers MB; Villiers CL; Jacquier-Sarlin MR; Gabert FM; Journet AM; Colomb MG
Immunology; 1996 Nov; 89(3):348-55. PubMed ID: 8958046
[TBL] [Abstract][Full Text] [Related]
76. Formation of covalent C3b-tetanus toxin complexes: a tool for the in vitro study of antigen presentation.
Villiers MB; Villiers CL; Wright JF; Maison CM; Colomb MG
Scand J Immunol; 1991 Nov; 34(5):585-95. PubMed ID: 1947794
[TBL] [Abstract][Full Text] [Related]
77. Involvement of the Zn-binding region of tetanus toxin in B and T recognition. Influence of Zn fixation.
Villiers MB; Gabert FM; Jacquier MR; Villiers CL; Colomb MG
Mol Immunol; 1993 Feb; 30(2):129-36. PubMed ID: 7679184
[TBL] [Abstract][Full Text] [Related]
78. Cellular immunology of tetanus toxoid.
Corradin G; Watts C
Curr Top Microbiol Immunol; 1995; 195():77-87. PubMed ID: 8542760
[No Abstract] [Full Text] [Related]
79. Determinant protection. A hypothesis for the activity of immune response genes in the processing and presentation of antigens by macrophages.
Werdelin O
Scand J Immunol; 1986 Dec; 24(6):625-36. PubMed ID: 2432653
[No Abstract] [Full Text] [Related]
80. Immunologic mechanisms in granulomatous lung disease.
Newman LS
Immunopharmacology; 2000 Jul; 48(3):329-31. PubMed ID: 10960678
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
